Skip to NavigationSkip to content

News

Venclexta/Venclyxto (venetoclax) successfully met its primary endpoint in Phase 3 trials, providing prolonged, progression-free survival in chronic...
Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal Products for...
Roche's Tecentriq has been added to the list of immunotherapy treatments placed on a partial hold by the FDA over safety concerns.
Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for $1.1 billion...
The swine flu pandemic that swept the world in 2009 may have had unforeseen consequences in some populations, after researchers discovered a link to...
Novartis has released new data demonstrating the efficacy of Xolair (omalizumab) in the treatment of chronic spontaneous urticaria (CSU), a severe...
The FDA has taken a major first step towards the digitisation of healthcare by approving the reSET app for substance use disorder, created by Pear...
Chinese conglomerate Fosun has agreed to acquire 74% of India’s Gland Pharma for $1.1 billion, sealing a previously unsuccessful deal which was...
The FDA gave Bayer priority review for its treatment Aliqopa (copanlisib) in May of this year, and it quickly came to judgement that the drug should...
Santhera Pharmaceutical has announced the EMA’s CHMP rejected its treatment for Duchenne muscular dystrophy (DMD) but revealed that it planned to...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches